Vascular Therapies, Inc.

Vascular Therapies, Inc.

Vascular Therapies, Inc.

Overview
Date Founded

2001

Headquarters

105 Union Avenue,Cresskil, NJ 07626

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Medical Products & Equipment
Wholesale: Consumer Non-Durables/Sundries
Biotechnology
Hospitals & Patient Services
Holding Companies

Company Description

Vascular Therapies, Inc. operates as a biopharmaceutical firm that develops and commercialize treatments of patients requiring an AV fistula for dialysis. It provides plan on the hemodialysis vascular access indication. The company was founded by Sriram Iyer in 2001 and is headquartered in Cresskill, NJ.

Executives & Employees

Chief Executive Officer

Board of Directors

Venture Advisor at New Enterprise Associates

Chairman & Chief Executive Officer at Teton Financial Services, Inc.

President at Clark Enterprises, Inc.

Chief Executive Officer at Vascular Therapies, Inc.

Co-Founder & Managing Partner at New Science Ventures LLC

Former Director at Power Medical Interventions, Inc.

Founder at Savitr Capital LLC

Member, Board of Directors at W.P. Carey, Inc.

Member, Board of Directors at Vascular Therapies, Inc.

Member, Board of Directors at Vascular Therapies, Inc.

Paths to Vascular Therapies, Inc.
Potential Connections via
Relationship Science
You
Vascular Therapies, Inc.
Recent Transactions
Details Hidden

Vascular Therapies, Inc. raised money in a private placement transaction

Details Hidden

Vascular Therapies, Inc. raised money in a private placement transaction

Details Hidden

Vascular Therapies, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onVascular Therapies, Inc. raised money in a private placement transaction

Investors
Details Hidden

New Science Ventures invests in life sciences & IT companies located in China, India, Europe and the US. The firm targets companies operating in the fields of pharmaceuticals, biologics, medical devices, and diagnostics and information technology.New Science Ventures target investment based on fundamental, science-based innovation, satisfy an unmet need and/or have a substantially better value proposition than current solutions, and address large markets, often with more than $1 billion in potential revenue. We invest in companies that have strong management, have defensible intellectual property, and are attractively valued so that large gains are possible. The firm invest in companies that have strong management, have defensible intellectual property, and are attractively valued so that large gains are possible.

Details Hidden

CNF Investments actively invests in venture capital and private equity opportunities. The firm focuses on investments in the life sciences, oil and gas, technology, telecommunications and alternative energy sectors. They invest primarily in early-stage and growth stage companies but also consider investments in later-stage companies and select public investments. CNF seeks to partner with other venture capital and private equity firms.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vascular Therapies, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vascular Therapies, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vascular Therapies, Inc..